The wide -spectrum new crown monoclonal antibody of mutant strains such as Omikon is clinical approval

On July 26, Zhu Jingjin, Secretary of the China Biological Party Committee of the Chinese Medicine Group, brought good news in an interview with the media before the China Biological Biological Show of the China International Consumer Products Expo: Recently, the reorganization of the reorganized all -person broad -spectrum virus sheet declared by the Chinese Biological Wuhan Biological Products Research Institute Clone antibodies (hereinafter referred to as "monoclonal anti -F61") obtained the clinical trial approval of the State Drug Administration.

The clinical approval of this monoclonal anti -F61 is of great significance and is an important weapon to deal with the epidemic of Omikon's mutation.

The monoclonal anti -anti -anti -F61 is developed by the Chinese Biological Yang Xiaoming team and the team of Liang Mifang's team of Researcher Liang Mifang in the Centers for Prevention and Control Center of the China Disease Control and Control Center. The antibody F61 is obtained from a single nuclear cells in a single nuclear cell in patients with new crowns. The current research results show that F61 is a broad-spectrum neutralized antibody, which has the neutralization of broad-spectrum, especially for the SARS-COV-2 prototypes and the world's major mutant strains. Each subtype (BA.1, BA.1.1, BA.2, BA.3 and BA.4/5) all have high neutralization.

Except for the monoclonal F61 treated in the early days after the infection of the new coronary virus, the research team of the two parties is also actively developing the F61 nasal spray that is used to prevent use.

At present, the number of people in the world's new crown epidemic has exceeded 500 million, and the cumulative death has more than 6 million people. The situation of the epidemic situation is still complicated and severe. Zhu Jingjin told reporters that Chinese biological Chinese creatures will go all out to promote the technological research on "diagnosis", "can be treated", "prevent" and various technological routes, accelerate the advancement of domestic and foreign clinical trials, promote research projects in research projects Emergency use or conditions to be listed, contributing more Chinese power to the construction of a community of human health and health!

Source: Chinese creature

- END -